Study of Undertreatment of Patients With Dyslipidemia in Bulgaria

Centralized Pan-Bulgarian Survey on the Undertreatment of Hypercholesterolemia

The purpose of this study is to establish the proportion of Bulgarian patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the Fourth Joint European Task Force guidelines.

Inclusion Criteria:

• Lipid lowering drug treatment for at least 3 months, with no dose change for a minimum of 6 weeks
• Signed Informed Consent

Exclusion Criteria:

• Informed Consent not provided